Skip to content

Clinical trials

Post-Acute COVID-19 Syndrome trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Country / region: Canada Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20215
202211
20238
20244
20257
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting13
Unknown status4
Active, not recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto4
University of Alberta4
University of Calgary3
Centre for Addiction and Mental Health2
Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec2
McMaster University2
University of Manitoba2
Université de Sherbrooke2
York University2
Association pour la Complementarite des Connaissances et des Pratiques de la Pneumologie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome40
COVID-1918
Fatigue Syndrome, Chronic6
Fatigue4
Mental Fatigue4
Cognitive Dysfunction3
Coronavirus Infections2
Postural Orthostatic Tachycardia Syndrome2
Anhedonia1
Anosmia1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.